BioAge Labs, Inc.
BIOA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $62,109 | $136,684 | $136,600 |
| - Cash | $354,349 | $21,644 | $27,644 |
| + Debt | $8,704 | $53,252 | $2,468 |
| Enterprise Value | -$283,536 | $168,292 | $111,424 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$68,575 | -$55,898 | -$39,352 |
| % Margin | – | – | – |
| Net Income | -$71,109 | -$63,854 | -$39,722 |
| % Margin | – | – | – |
| EPS Diluted | -6.63 | -8.55 | -5.32 |
| % Growth | 22.5% | -60.7% | – |
| Operating Cash Flow | -$51,522 | -$37,362 | -$36,181 |
| Capital Expenditures | -$366 | -$166 | -$103 |
| Free Cash Flow | -$51,888 | -$37,528 | -$36,284 |